Pionyr Immunotherapeutics

Share on: 
Business Area(s): 

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity. The company is exploiting novel target discovery and antibody generation platform technologies to create the next generation of immuno-oncology therapeutics.

South San Francisco CA
United States